Watson RM - Search Results

1

Inhibition of exercise-induced bronchoconstriction by MK-571, a potent leukotriene D4-receptor antagonist.

Manning PJ, Watson RM, Margolskee DJ, Williams VC, Schwartz JI, O'Byrne PM. Manning PJ, et al. Among authors: watson rm. N Engl J Med. 1990 Dec 20;323(25):1736-9. doi: 10.1056/NEJM199012203232504. N Engl J Med. 1990. PMID: 2174121 Free article. Clinical Trial.

2

Tachyphylaxis to inhaled methacholine in normal but not asthmatic subjects.

Stevens WH, Manning PJ, Watson RM, O'Byrne PM. Stevens WH, et al. Among authors: watson rm. J Appl Physiol (1985). 1990 Sep;69(3):875-9. doi: 10.1152/jappl.1990.69.3.875. J Appl Physiol (1985). 1990. PMID: 2246174 Clinical Trial.

3

Effect of inhaled PGE2 on exercise-induced bronchoconstriction in asthmatic subjects.

Melillo E, Woolley KL, Manning PJ, Watson RM, O'Byrne PM. Melillo E, et al. Among authors: watson rm. Am J Respir Crit Care Med. 1994 May;149(5):1138-41. doi: 10.1164/ajrccm.149.5.8173753. Am J Respir Crit Care Med. 1994. PMID: 8173753 Clinical Trial.

4

Exercise-induced refractoriness in asthmatic subjects involves leukotriene and prostaglandin interdependent mechanisms.

Manning PJ, Watson RM, O'Byrne PM. Manning PJ, et al. Among authors: watson rm. Am Rev Respir Dis. 1993 Oct;148(4 Pt 1):950-4. doi: 10.1164/ajrccm/148.4_Pt_1.950. Am Rev Respir Dis. 1993. PMID: 8214949 Clinical Trial.

5

Effect of a platelet activating factor antagonist, WEB 2086, on allergen induced asthmatic responses.

Freitag A, Watson RM, Matsos G, Eastwood C, O'Byrne PM. Freitag A, et al. Among authors: watson rm. Thorax. 1993 Jun;48(6):594-8. doi: 10.1136/thx.48.6.594. Thorax. 1993. PMID: 8346486 Free PMC article. Clinical Trial.

6

Factors contributing to dyspnoea during bronchoconstriction and exercise in asthmatic subjects.

Killian KJ, Summers E, Watson RM, O'Byrne PM, Jones NL, Campbell EJ. Killian KJ, et al. Among authors: watson rm. Eur Respir J. 1993 Jul;6(7):1004-10. Eur Respir J. 1993. PMID: 8370426

7

Attenuation of early and late phase allergen-induced bronchoconstriction in asthmatic subjects by a 5-lipoxygenase activating protein antagonist, BAYx 1005.

Hamilton AL, Watson RM, Wyile G, O'Byrne PM. Hamilton AL, et al. Among authors: watson rm. Thorax. 1997 Apr;52(4):348-54. doi: 10.1136/thx.52.4.348. Thorax. 1997. PMID: 9196518 Free PMC article. Clinical Trial.

8

Pranlukast, a cysteinyl leukotriene receptor antagonist, attenuates allergen-induced early- and late-phase bronchoconstriction and airway hyperresponsiveness in asthmatic subjects.

Hamilton A, Faiferman I, Stober P, Watson RM, O'Byrne PM. Hamilton A, et al. Among authors: watson rm. J Allergy Clin Immunol. 1998 Aug;102(2):177-83. doi: 10.1016/s0091-6749(98)70083-1. J Allergy Clin Immunol. 1998. PMID: 9723658 Clinical Trial.

9

Protective effects of inhaled PGE2 on allergen-induced airway responses and airway inflammation.

Gauvreau GM, Watson RM, O'Byrne PM. Gauvreau GM, et al. Among authors: watson rm. Am J Respir Crit Care Med. 1999 Jan;159(1):31-6. doi: 10.1164/ajrccm.159.1.9804030. Am J Respir Crit Care Med. 1999. PMID: 9872814 Clinical Trial.

10

Effect of inhaled leukotriene D4 on airway eosinophilia and airway hyperresponsiveness in asthmatic subjects.

Mulder A, Gauvreau GM, Watson RM, O'byrne PM. Mulder A, et al. Among authors: watson rm. Am J Respir Crit Care Med. 1999 May;159(5 Pt 1):1562-7. doi: 10.1164/ajrccm.159.5.9810095. Am J Respir Crit Care Med. 1999. PMID: 10228127 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

224 results

Search Page

Filters